Clinical implications of bovine spongiform encephalopathy

Authors
Citation
C. Macknight, Clinical implications of bovine spongiform encephalopathy, CLIN INF D, 32(12), 2001, pp. 1726-1731
Citations number
37
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
32
Issue
12
Year of publication
2001
Pages
1726 - 1731
Database
ISI
SICI code
1058-4838(20010615)32:12<1726:CIOBSE>2.0.ZU;2-K
Abstract
Bovine spongiform encephalopathy (BSE) is a new prion disease that was firs t identified in the United Kingdom in 1987. Its appearance was likely cause d by changes in the rendering process used to produce a meat and bone suppl ement for cattle, changes that allowed this prion to enter the bovine food supply. Despite measures that were made to reduce the risk to humans, a new variant of Creutzfeldt-Jakob disease appeared in the mid-1990s and has bee n linked to BSE. Although the extent of the disease's impact on humans is n ot yet known, current estimates predict that there will be 136,000 cases of this fatal disease by the year 2040. The risk to humans of medications pro duced with bovine materials, gelatin, and blood transfusion is unknown.